| # | Drug | Count |
|---|---|---|
| 0 | LETROZOLE | 60 |
| 1 | LETROZOLE TABLETS | 58 |
| 2 | RIBOCICLIB | 33 |
| 3 | EXEMESTANE | 31 |
| 4 | EVEROLIMUS | 27 |
| 5 | FULVESTRANT | 27 |
| 6 | LEVONORGESTREL | 27 |
| 7 | PACLITAXEL | 27 |
| 8 | CAPECITABINE | 24 |
| 9 | EVEROLIMUS TABLETS | 23 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY | 1 | 0.0278 |
| 1 | FORMALDEHYDE | 1 | 0.0164 |
| 2 | METHENAMINE MANDELATE | 1 | 0.0053 |
| 3 | ESTRADIOL ACETATE | 3 | 0.0038 |
| 4 | TAMOXIFEN CITRATE | 14 | 0.0024 |
| 5 | DEXRAZOXANE FOR INJECTION | 2 | 0.0021 |
| 6 | VINORELBINE | 11 | 0.0016 |
| 7 | BEPOTASTINE BESILATE | 1 | 0.0016 |
| 8 | EXEMESTANE | 31 | 0.0014 |
| 9 | EPIRUBICIN HYDROCHLORIDE | 9 | 0.0014 |
| # | Drug class | Count |
|---|---|---|
| 0 | Aromatase Inhibitor [EPC] | 85 |
| 1 | Kinase Inhibitor [EPC] | 46 |
| 2 | Microtubule Inhibitor [EPC] | 34 |
| 3 | Progestin [EPC] | 30 |
| 4 | Estrogen Receptor Antagonist [EPC] | 27 |
| 5 | Progestin-containing Intrauterine System [EPC] | 27 |
| 6 | mTOR Inhibitor Immunosuppressant [EPC] | 27 |
| 7 | Nucleoside Metabolic Inhibitor [EPC] | 26 |
| 8 | Platinum-based Drug [EPC] | 22 |
| 9 | Alkylating Drug [EPC] | 21 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Guanylate Cyclase-C Agonist [EPC] | 2 | 0.0010 |
| 1 | Aromatase Inhibitor [EPC] | 85 | 0.0007 |
| 2 | Estrogen Receptor Antagonist [EPC] | 27 | 0.0007 |
| 3 | Provitamin D2 Compound [EPC] | 9 | 0.0003 |
| 4 | HER2/neu Receptor Antagonist [EPC] | 18 | 0.0002 |
| 5 | Microtubule Inhibitor [EPC] | 34 | 0.0002 |
| 6 | Insulin-like Growth Factor-1 Receptor Inhibitor [EPC] | 1 | 0.0002 |
| 7 | Interleukin-13 Antagonist [EPC] | 1 | 0.0001 |
| 8 | Androgen [EPC] | 3 | 0.0001 |
| 9 | Interleukin-17A Antagonist [EPC] | 4 | 0.0001 |